Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas
June 1, 2026
After 10 years one third of the heavily pretreated lymphoma patients who had CAR-T therapy stayed disease free.
After 10 years one third of the heavily pretreated lymphoma patients who had CAR-T therapy stayed disease free.